EXTENDICARE INC (EXE.CA) Fundamental Analysis & Valuation
TSX:EXE • CA30224T8639
Current stock price
30.14 CAD
+0.24 (+0.8%)
Last:
This EXE.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. EXE.CA Profitability Analysis
1.1 Basic Checks
- In the past year EXE was profitable.
- EXE had a positive operating cash flow in the past year.
- In the past 5 years EXE has always been profitable.
- Each year in the past 5 years EXE had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of EXE (9.06%) is better than 100.00% of its industry peers.
- EXE's Return On Equity of 25.89% is amongst the best of the industry. EXE outperforms 91.67% of its industry peers.
- EXE has a Return On Invested Capital of 14.09%. This is amongst the best in the industry. EXE outperforms 91.67% of its industry peers.
- EXE had an Average Return On Invested Capital over the past 3 years of 14.71%. This is significantly above the industry average of 6.93%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.06% | ||
| ROE | 25.89% | ||
| ROIC | 14.09% |
ROA(3y)8.19%
ROA(5y)6.95%
ROE(3y)41.67%
ROE(5y)41.08%
ROIC(3y)14.71%
ROIC(5y)10.79%
1.3 Margins
- EXE has a Profit Margin of 5.82%. This is amongst the best in the industry. EXE outperforms 91.67% of its industry peers.
- In the last couple of years the Profit Margin of EXE has grown nicely.
- Looking at the Operating Margin, with a value of 8.35%, EXE is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of EXE has remained more or less at the same level.
- EXE has a worse Gross Margin (14.26%) than 83.33% of its industry peers.
- EXE's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.35% | ||
| PM (TTM) | 5.82% | ||
| GM | 14.26% |
OM growth 3Y57.94%
OM growth 5Y0.49%
PM growth 3Y0.74%
PM growth 5Y4.46%
GM growth 3Y17.09%
GM growth 5Y-1.93%
2. EXE.CA Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXE is creating value.
- EXE has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for EXE has been increased compared to 5 years ago.
- EXE has a better debt/assets ratio than last year.
2.2 Solvency
- EXE has an Altman-Z score of 4.17. This indicates that EXE is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 4.17, EXE belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
- EXE has a debt to FCF ratio of 3.18. This is a good value and a sign of high solvency as EXE would need 3.18 years to pay back of all of its debts.
- EXE has a Debt to FCF ratio of 3.18. This is amongst the best in the industry. EXE outperforms 83.33% of its industry peers.
- EXE has a Debt/Equity ratio of 0.83. This is a neutral value indicating EXE is somewhat dependend on debt financing.
- EXE's Debt to Equity ratio of 0.83 is in line compared to the rest of the industry. EXE outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 3.18 | ||
| Altman-Z | 4.17 |
ROIC/WACC1.81
WACC7.8%
2.3 Liquidity
- A Current Ratio of 1.37 indicates that EXE should not have too much problems paying its short term obligations.
- EXE has a better Current ratio (1.37) than 91.67% of its industry peers.
- A Quick Ratio of 1.37 indicates that EXE should not have too much problems paying its short term obligations.
- With an excellent Quick ratio value of 1.37, EXE belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 |
3. EXE.CA Growth Analysis
3.1 Past
- EXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.99%, which is quite impressive.
- The Earnings Per Share has been growing by 15.56% on average over the past years. This is quite good.
- The Revenue has grown by 13.25% in the past year. This is quite good.
- EXE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.47% yearly.
EPS 1Y (TTM)40.99%
EPS 3Y12.58%
EPS 5Y15.56%
EPS Q2Q%34.86%
Revenue 1Y (TTM)13.25%
Revenue growth 3Y10.77%
Revenue growth 5Y7.47%
Sales Q2Q%18%
3.2 Future
- EXE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.95% yearly.
- Based on estimates for the next years, EXE will show a quite strong growth in Revenue. The Revenue will grow by 13.52% on average per year.
EPS Next Y16.31%
EPS Next 2Y16.61%
EPS Next 3Y15.95%
EPS Next 5YN/A
Revenue Next Year32.28%
Revenue Next 2Y19.54%
Revenue Next 3Y13.52%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. EXE.CA Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 27.15, EXE can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 83.33% of the companies listed in the same industry.
- EXE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.54.
- EXE is valuated rather expensively with a Price/Forward Earnings ratio of 24.61.
- EXE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXE is cheaper than 75.00% of the companies in the same industry.
- EXE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.15 | ||
| Fwd PE | 24.61 |
4.2 Price Multiples
- 66.67% of the companies in the same industry are more expensive than EXE, based on the Enterprise Value to EBITDA ratio.
- EXE's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.46 | ||
| EV/EBITDA | 15.98 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of EXE may justify a higher PE ratio.
- A more expensive valuation may be justified as EXE's earnings are expected to grow with 15.95% in the coming years.
PEG (NY)1.67
PEG (5Y)1.74
EPS Next 2Y16.61%
EPS Next 3Y15.95%
5. EXE.CA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.84%, EXE has a reasonable but not impressive dividend return.
- EXE's Dividend Yield is a higher than the industry average which is at 1.49.
- Compared to an average S&P500 Dividend Yield of 1.82, EXE has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
5.2 History
- The dividend of EXE has a limited annual growth rate of 0.28%.
- EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.28%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 43.14% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
- EXE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.14%
EPS Next 2Y16.61%
EPS Next 3Y15.95%
EXE.CA Fundamentals: All Metrics, Ratios and Statistics
TSX:EXE (4/28/2026, 7:00:00 PM)
30.14
+0.24 (+0.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength78.74
Industry Growth83.58
Earnings (Last)02-26 2026-02-26
Earnings (Next)05-07 2026-05-07
Inst Owners24.54%
Inst Owner ChangeN/A
Ins Owners1.19%
Ins Owner ChangeN/A
Market Cap2.85B
Revenue(TTM)1.66B
Net Income(TTM)96.66M
Analysts78
Price Target31 (2.85%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
Yearly Dividend0.47
Dividend Growth(5Y)0.28%
DP43.14%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-30 2026-04-30 (0.0441)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)26.9%
PT rev (3m)25.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)7.3%
EPS NY rev (3m)4.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-2.89%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.15 | ||
| Fwd PE | 24.61 | ||
| P/S | 1.71 | ||
| P/FCF | 27.46 | ||
| P/OCF | 17.4 | ||
| P/B | 7.63 | ||
| P/tB | 15.99 | ||
| EV/EBITDA | 15.98 |
EPS(TTM)1.11
EY3.68%
EPS(NY)1.22
Fwd EY4.06%
FCF(TTM)1.1
FCFY3.64%
OCF(TTM)1.73
OCFY5.75%
SpS17.58
BVpS3.95
TBVpS1.89
PEG (NY)1.67
PEG (5Y)1.74
Graham Number9.9357 (-67.03%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.06% | ||
| ROE | 25.89% | ||
| ROCE | 18.83% | ||
| ROIC | 14.09% | ||
| ROICexc | 26.71% | ||
| ROICexgc | 53.72% | ||
| OM | 8.35% | ||
| PM (TTM) | 5.82% | ||
| GM | 14.26% | ||
| FCFM | 6.24% |
ROA(3y)8.19%
ROA(5y)6.95%
ROE(3y)41.67%
ROE(5y)41.08%
ROIC(3y)14.71%
ROIC(5y)10.79%
ROICexc(3y)22.22%
ROICexc(5y)15.92%
ROICexgc(3y)39.32%
ROICexgc(5y)26.96%
ROCE(3y)19.66%
ROCE(5y)14.43%
ROICexgc growth 3Y88.69%
ROICexgc growth 5Y25.88%
ROICexc growth 3Y67.25%
ROICexc growth 5Y13.75%
OM growth 3Y57.94%
OM growth 5Y0.49%
PM growth 3Y0.74%
PM growth 5Y4.46%
GM growth 3Y17.09%
GM growth 5Y-1.93%
F-Score6
Asset Turnover1.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 3.18 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 162.15% | ||
| Cap/Sales | 3.61% | ||
| Interest Coverage | 12.73 | ||
| Cash Conversion | 93.15% | ||
| Profit Quality | 107.28% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 4.17 |
F-Score6
WACC7.8%
ROIC/WACC1.81
Cap/Depr(3y)229.86%
Cap/Depr(5y)237.24%
Cap/Sales(3y)5.46%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.99%
EPS 3Y12.58%
EPS 5Y15.56%
EPS Q2Q%34.86%
EPS Next Y16.31%
EPS Next 2Y16.61%
EPS Next 3Y15.95%
EPS Next 5YN/A
Revenue 1Y (TTM)13.25%
Revenue growth 3Y10.77%
Revenue growth 5Y7.47%
Sales Q2Q%18%
Revenue Next Year32.28%
Revenue Next 2Y19.54%
Revenue Next 3Y13.52%
Revenue Next 5YN/A
EBIT growth 1Y24.69%
EBIT growth 3Y74.95%
EBIT growth 5Y7.99%
EBIT Next Year53.59%
EBIT Next 3Y21.49%
EBIT Next 5YN/A
FCF growth 1Y1.97%
FCF growth 3YN/A
FCF growth 5Y3.29%
OCF growth 1Y13.89%
OCF growth 3Y18.28%
OCF growth 5Y6.16%
EXTENDICARE INC / EXE.CA Fundamental Analysis FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
What is the valuation status for EXE stock?
ChartMill assigns a valuation rating of 4 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.
How profitable is EXTENDICARE INC (EXE.CA) stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 7 / 10.
What is the valuation of EXTENDICARE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EXTENDICARE INC (EXE.CA) is 27.15 and the Price/Book (PB) ratio is 7.63.
How financially healthy is EXTENDICARE INC?
The financial health rating of EXTENDICARE INC (EXE.CA) is 7 / 10.